Prolonged exposure (8-24 h) of human promonocytic U937 cells to 100 nM l-O-hexadecyl-2-N-methylcarbamyl-sn-glycero-3-phosphocholine (carbarmyl-PAF), a non-metabolizable analogue of platelet-activating factor (PAF), reduced the numbers of PAF receptors by 50-75 %, as determined by the radioligandbinding assay. To clarify whether the down-regulation of receptor numbers is due to decreased expression level of the PAF-receptor gene, the effect of carbamyl-PAF on the steady-state level of PAF-receptor mRNA was examined by a highly sensitive reversetranscriptase PCR method. A 50 % decline in the level of PAFreceptor mRNA was observed in U937 cells pretreated with 100 nM carbamyl-PAF for 24 h. The effect of carbamyl-PAF was dose-dependent, with an EC50 value around 10 nM. A PAF-
INTRODUCTION
Platelet-activating factor (PAF) is a potent inflammatory mediator which exerts diverse biological effects on a variety of cells, including platelets, neutrophils, macrophages, smooth-muscle cells, endothelial cells and nerve cells (Hanahan, 1986; Braquet et al., 1987; Snyder, 1990; Venable et al., 1993) . The biological effects of PAF are mediated by specific receptor proteins on cell surfaces. Studies on a number of cell types have demonstrated that activation of the PAF receptor leads to membrane polyphosphoinositide breakdown, calcium influx, and tyrosine phosphorylation (Shukla, 1992; Shimizu et al., 1992) . Recently, the cDNA for the PAF receptor has been cloned from guinea-pig lung and human leucocytes Ye et al., 1991; Kunz et al., 1992) . The deducted amino acid sequence revealed that the receptor contains a seven-a-helix transmembrane structure, which is characteristic of the Gprotein-coupled receptors (Dohlman et al., 1991) . As commonly observed in many receptors, activation of the PAF receptor by agonist leads to loss of responsiveness or 'desensitization' of receptor (Morrison and Shukla, 1988; Homma and Hanahan, 1988; Schwertschlag and Whorton, 1988; Barzaghi et al., 1989 ; Grandison, 1990) , but the underlying mechanism has not yet been clarified. Nevertheless, studies on other G-protein-coupled receptors, such as the /82-adrenergic receptor and the muscarinic acetylcholine receptor, have demonstrated that desensitization occurring in the early phase after activation results from phosphorylation of the receptor proteins, sequestration or decreased numbers of receptors on the cell surfaces and uncoupling of the receptors from effectors (Galper et al., 1982; Bouvier et al., 1988; Benovic et al., 1988; Lohse et al., 1990) . During the later phase (up to several hours), down-regulation of the receptor transcripts has been observed (Hadcock and Malbon, 1988;  receptor antagonist, SRI-63675, was able to attenuate the effect of carbamyl-PAF. Furthermore lysoPAF, at 1 uM, was unable to induce a significant decrease in PAF-receptor mRNA after incubation for 24 h, indicating that the effect of carbamyl-PAF was specific. The half-life of the PAF-receptor mRNA measured in the presence of actinomycin D was unaffected by carbamyl-PAF treatment. In contrast, nuclear run-off experiments demonstrated that the transcription rate of the PAF-receptor gene in carbamyl-PAF-treated cells was about 65 % of that in control cells. These results suggest that the PAF receptor in U937 cells is subject to down-regulation by agonist, at least partly, at the transcriptional level. Hadcock et al., 1989; Habecker and Nathanson, 1992; Longone et al., 1993; Steel and Buckley, 1993) . Apparently the receptors are subject to regulation by agonists at both protein and mRNA levels. Therefore we were interested to know whether the PAF receptor is also subject to regulation by agonist in a similar manner. In this study, we used human promonocyte-like U937 cells, which are known to respond to PAF (Barzaghi et al., 1989; Ong et al., 1991) as a model to study the effect of agonist stimulation on the expression of the PAF-receptor gene. A highly sensitive reverse-transcriptase PCR (RT-PCR) method was employed to quantify the steady-state level ofPAF-receptor mRNA, which is normally not abundant in cells. It was shown that longterm incubation of the cells with 1-O-hexadecyl-2-N-methylcarbamyl-sn-glycero-3-phosphocholine (carbamyl-PAF), a nonmetabolizable analogue of PAF (O'Flaherty et al., 1987; Tessner et al., 1989) Determination of PAF-receptor-binding acftvity U937 cells (1 x 108) were incubated with or without 100 nM carbamyl-PAF at 37 'C for indicated times. BSA was then added to the medium to achieve a final concentration of 2.5 % and the incubation was continued for 10 min. Cells were harvested by centrifugation at 500 g for 5 min and washed once with cold PBS. Membrane fractions were prepared and the PAF-receptorbinding activity was measured by a radioligand-binding assay as described previously (Chau et al., 1992) .
Total RNA extraction Total RNA was isolated from cells by the acid guanidium thiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987) with some modification. Briefly, following the first extraction by acid guanidinium thiocyanatephenol-chloroform, the RNA in the aqueous phase was re-extracted once by adding an equal volume of phenol and a one-tenth volume of a chloroform-isoamyl alcohol mixture (49: 1, v/v). After mixing, the sample was centrifuged again at 10000 g for 20 min at 4 'C. The aqueous phase was removed and the RNA was precipitated by adding a half volume of ethanol and placing at -70 'C for at least 1 h. The quality of the RNA was checked by the ratio of the A260/A280 (2-1.8) and agarose gel electrophoresis.
Quantitative RT-PCR A sample (1 ug) of total RNA was reverse-transcribed into cDNA by incubating it with 200 units of Maloney leukemia transcriptase in 20 ,u of reaction buffer containing 10 units of RNAsin, 0.2 ug of random hexamers and 0.8 mM dNTPs at 37 'C for 1 h. The reaction was terminated by heating at 95 'C for 10 min and the mixture diluted to 500,1 with deionized water. Aliquots were taken for PCR amplification with either PAF-receptor-specific primers or glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific primers. The sequences of the sense and antisense primers for the PAF receptor were: sense-5'-TATAACCGCTTCCAGGCAGT-3', antisense-5'-GAAACA-GTAGATAACAGGGTC-3'. The sense and antisense primers for GAPDH were: 5'-CCACCCATGGCAAATTCCATGGCA-3' and 5'-TCTAGACGGCAGGTCAGGTCCACC-3'. The PCR was performed in 50 ,ul of 10 mM Tris/HCI, pH 8.3, containing 50 mM KC1, 1.5 mM MgCI2, 0.001 % (w/v) gelatin, 0.2 mM dATP, 0.2 mM dCTP, 0.2 mM dTTP, 0.2 mM dGTP, 1 ,M of each primer, and 1.25 units of AmpliTaq DNA polymerase. The reaction proceeded for 25 cycles of denaturation at 94 'C for 1 min, annealing at 55 'C for 1 min, and extension at 72 'C for 1 min. Amplified cDNAs were electrophoresed on 1 % (w/v) agarose gels containing ethidium bromide (1 ,ug/ml). The expected sizes of the cDNA fragments for both the PAF receptor and GAPDH were around 0.55 kb. The cDNA was quantified by an in-house assembled laser-excited confocal fluorescence gel Determination of mRNA decay U937 cells were pretreated with or without 100 nM carbamyl-PAF at 37°C for 24 h in Opti-MEM. Actinomycin D was then added to the medium to achieve a final concentration of 10 ,ug/ml, at which concentration cell viability was not significantly affected during a 6-h incubation. Cells were harvested at the indicated time points and the total RNA was isolated. Ethidium bromidestaining of the RNA isolated at time zero and after 1 h and 3 h showed no sign of degradation; whereas some degree of RNA breakdown of the 28S RNA was noticed at 6 h. The PAFreceptor transcript was quantified by RT-PCR as described above.
Nuclear run-off Cells [(1-2) x 107] pretreated with or without 100 nM carbamyl-PAF for 24 h were harvested and washed twice with cold PBS. The cell pellet was resuspended in 1 ml of Nonidet lysis buffer containing 10 mM Tris/HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl2 and 0.5 % (v/v) NP-40. After incubation at 4°C for 5 min, nuclei were collected by centrifugation at 500 g for 5 ( Morrison and Shukla, 1988; Homma and Hanahan, 1988; Schwertschlag and Whorton, 1988; Barzaghi et al., 1989; Grandison, 1990 Figure 1 , the amounts of cDNA produced were proportional to the inputs of the RT-PCR products for both the PAF receptor and GAPDH. DNA sequencing of the PCR fragments confirmed they were the right products (results not shown). Therefore, in subsequent experiments, the amounts of reverse-transcriptase products taken for PCR amplification of the PAF receptor and GAPDH were within the linear ranges, in order to ensure that the amounts of cDNA produced truly reflect the levels of mRNA in the original samples. When U937 cells were incubated with 100 nM carbamyl-PAF for long periods of time (> 8 h), the PAF-receptor mRNA level declined significantly i.e. by 50% after 24 h (Figure 2) . However, the time course for the decline in PAF-receptor mRNA appeared to be much slower than that for the decrease in receptor numbers (Table 1) . Furthermore, the percentage of the receptors lost after carbamyl-PAF treatment was much greater than could be accounted for solely by the decrease in receptor mRNA. We speculated that prolonged exposure of cells to carbamyl-PAF might also lead to increased degradation of the PAF receptor, as observed for the muscarinic receptor (Klein et al., 1979; Galper and Smith, 1980) . The effect of carbamyl-PAF was dose-dependent, with an EC50 value of around 1O nM (Figure 3) , which is comparable with the EC50 value for eliciting a degranulation response in neutrophils (O'Flaherty et al., 1987 periment was conducted to examine the effect of a PAF antagonist. As shown in Table 2 , when the PAF antagonist SRI-63675 (Handley et al., 1987) receptor, is subject to down-regulation by agonist at the mRNA level. Since the decrease in the steady-state level of the PAFreceptor mRNA might have resulted either from a decrease in the rate of transcription of the gene encoding the PAF receptor, or from an increase in the rate of degradation of the PAF-receptor transcript, we investigated the underlying mechanism by which the PAF-receptor mRNA was down-regulated by agonist further. Cells were preincubated with or without 100 nM carbamyl-PAF for 24 h and then harvested at 0, 1, 3, or 6 h after the addition of the transcription blocker actinomycin D at a concentration of tg/ml. As illustrated in Figure 4 , the half-life of the PAFreceptor mRNA in U937 cells was about 2 h, which is similar to that reported for peripheral blood monocytes (Thivierge et al., 1993) . Pretreatment of U937 cells with carbamyl-PAF did not significantly decrease the half-life of PAF-receptor mRNA, suggesting that the changes in the PAF-receptor mRNA in agonist-treated cells were not due to altered stability of the receptor transcript. Therefore, nuclear run-off experiments were conducted to monitor the rate of transcription of the PAF receptor in U937 cells after agonist stimulation. Figure 5 clearly shows that the rate of PAF-receptor-gene transcription in nuclei isolated from carbamyl-PAF-treated cells was about 650% of that in nuclei from control cells, which correlates with the percentage decline in PAF-receptor mRNA in agonist-treated cells. This observation differs from that reported for the i2-adrenergic receptor in which agonist-induced down-regulation of receptor transcripts resulted from destabilization of the receptor mRNA (Hadcock et al., 1989) . Nevertheless, an agonist-induced decrease in receptor-gene transcription has also been suggested for the muscarinic receptor (Longone et al., 1993 (Hadcock and Malbon, 1988) , and the second messengers derived from both the adenylate cyclase and phospholipase C pathways have also been shown to be involved in regulation of muscarinic receptor gene expression (Habecker et al., 1993) . Stimulation of U937 cells by PAF leads to activation of phospholipase C (Barzaghi et al., 1989) as well as phospholipase D (Balsinde and Mollinedo, 1991) and the subsequent generation of the second messengers diacylglycerol, inositol trisphosphate, and phosphatidate, which can then trigger activation of protein kinase C and release of Ca2+ from intracellular stores (Moolenaar et al., 1986; Berridge, 1987) . Whether these signals are involved in mediating agonist-induced down-regulation of PAF-receptor gene transcription remains to be clarified. In summary, the present study demonstrates that the PAF receptor is down-regulated following prolonged agonist treatment of U937 cells. The marked reduction in receptor numbers was due, at least in part, to a decline in the steady-state level of receptor mRNA, which was correlated with a decrease in the transcriptional rate of the receptor gene. Although the molecular mechanism underlying transcriptionat regulation of the PAF 
